Baxter International
Large Cap · Healthcare · Medical Instruments & Supplies
$25.93+$0.02 (+0.08%)
Baxter International
Large Cap · Healthcare · Medical Instruments & Supplies
$25.93+$0.02 (+0.08%)
Stock analysis
Get the AI take on BAX
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$15.73
High$28.94
Today $25.93
RSI (14)
56.5Neutral
03070100
Overall score
36/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$23
Current price
$25.93
Median target
$28
Highest
$40
LowHigh
Operating Record
Revenue
What's working
- Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
- Price / sales: You're paying a modest amount for each dollar of revenue coming in.
What to watch
- Debt exceeds cash by $7.5B, increasing balance-sheet pressure, a warning sign.
- ROIC: Capital plowed back into the business isn't earning much for its trouble.
What the market charges
Forward P/E
Favorable · 40% below avg
12.69x
Price / sales
Strong · Priced modestly against the revenue it brings in
1.20x
Price / FCF
Strong · Priced well within what its cash flow supports
16.96x
EV / EBITDA
Strong · Operating earnings comfortably support this price
11.33x
How efficiently it compounds
ROIC
Weak · Struggling to earn much on the capital it uses
6.8%
ROE
Needs attention · Unfavorable
-14.4%
Debt / equity
Needs attention · Unfavorable
1.56x
Current ratio
Strong · Comfortable room to cover bills due within a year
1.95x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $13.82B | - | +5.4% | 36 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |